Pediatric asthma guidelines for children aged 5 years and above, outlining diagnosis criteria, symptom patterns, and treatment recommendations based on GINA 2023. The content covers characteristics suggestive of asthma, including recurrent non-productive cough, wheezing, and shortness of breath, and

3 views • 30 slides

Adrenergic agents play a crucial role in pharmacology by influencing the sympathetic nervous system through adrenergic receptors. These agents, such as sympathomimetics and sympatholytics, impact essential functions like cardiac activity, blood vessel dilation, and insulin release. Adrenergic neurot

0 views • 120 slides

This update covers key aspects of managing type 2 diabetes and addressing cardiovascular risks, including discussions on GLP-1 receptor agonists, patient safety concerns, evidence-based recommendations, and individualized therapy approaches. It also includes a patient case study highlighting the imp

3 views • 52 slides

GLP-1 receptor agonists offer a promising therapeutic approach for weight management in individuals with HIV. Weight gain is a common issue, exacerbated by antiretroviral therapy, and can lead to metabolic risks. This presentation by Dr. Suman Srinivasa discusses the potential of GLP-1 receptor agon

2 views • 32 slides

Explore the pharmacology of the autonomic nervous system focusing on cholinergic and adrenergic agents. Learn about cholinomimetics, direct and indirect acting cholinergic agonists, their therapeutic indications, and adverse effects. Discover the mechanism of action and uses of nicotinic agonists. D

1 views • 44 slides

Clonisor is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Clonidine belongs to a class of drugs (central alpha agonists) that act in the brain to lower blood

1 views • 1 slides

Anxiety disorders are conditions characterized by excessive worry and fear that can interfere with daily life. Common types include generalized anxiety disorder, panic disorder, phobias, and OCD. Treatment options include psychotherapy and anxiolytic drugs such as benzodiazepines, 5HT1A agonists, be

0 views • 25 slides

Adrenergic transmission involves the release of neurotransmitters such as norepinephrine, dopamine, and epinephrine at synapses or neuroeffector junctions. These neurotransmitters, known as catecholamines, play crucial roles in transmitting impulses in the sympathetic nervous system and central nerv

0 views • 14 slides

Cholinergic neurons play a vital role in neurotransmission by utilizing acetylcholine (ACh) as a neurotransmitter. This neurotransmission involves steps like synthesis, storage in vesicles, release, receptor binding, degradation, and recycling of choline and acetate. Choline acetyltransferase cataly

0 views • 30 slides

Understanding the mechanism of ovulation and hormonal regulation is key in classifying drugs used to induce ovulation. This lecture covers the pharmacology of different groups of drugs, their mechanisms of action, administration protocols, indications, efficacy rates, and adverse effects. Antiestrog

0 views • 6 slides

Explore the mechanisms of action of adrenergic neuron blockers and classify adrenergic receptor blockers into selective and non-selective categories. Delve into the pharmacokinetic aspects and pharmacodynamic effects of these blockers, such as false transmitter formation, store depletion, release in

0 views • 29 slides

Opioids are essential in treating severe and chronic pain, whether malignant or nonmalignant. They are classified based on chemical structure, aiding in identifying potential cross-sensitivity in patients. Opioid agonists interact with specific receptors in the central nervous system and peripheral

0 views • 45 slides

Asthma in athletes can impact performance and health, with triggers like exercise-induced asthma posing challenges. Key considerations include having rescue inhalers available, regular asthma management examinations, and proper warm-ups. Treatment for exercise-induced asthma often involves beta2-ago

0 views • 8 slides

The rise of GLP-1 medications as a groundbreaking solution for medical weight loss. It delves into the science behind GLP-1 receptor agonists, their benefits, and the growing body of research supporting their use. Additionally, it examines the increa

1 views • 2 slides

Overview of pharmacological treatment options for Parkinson's disease and related conditions like choreatic dyskinesias, spastic disorders, and myasthenia gravis. Describes the degenerative process of Parkinson's disease, its symptoms, and the pharmacological interventions targeting dopamine deficit

0 views • 26 slides

This content delves into the fundamentals of neuropharmacology, exploring concepts such as dose-response curves, afferent and efferent neurons, peripheral nervous system divisions, neurotransmitter functions, and neurochemical classifications. It covers the roles of cholinergic, adrenergic, and dopa

0 views • 29 slides

Adrenergic neurotransmission, mediated by norepinephrine, dopamine, and epinephrine, plays a crucial role in various physiological processes. This process involves synthesis, storage, release, and termination of catecholamines like norepinephrine and epinephrine. The intricate mechanisms of neurotra

0 views • 12 slides

This academic session covers the effect of autonomic nervous system stimulation on various systems, clinical diseases, pathophysiological changes, disease management guidelines, and clinical applications of autonomic drugs. Common clinical applications of autonomic receptors agonists and antagonists

0 views • 23 slides

Explore guidelines for medication-assisted treatment during intrapartum and postpartum periods, emphasizing pain management strategies for opioid-dependent patients. Tips include adjusting dosages, adding NSAIDs, and considering opioid agonists with high mu receptor affinity. Careful monitoring and

0 views • 12 slides

GLP-1 receptor agonists are newer non-insulin-based glucose-lowering therapies with demonstrated cardiovascular benefits. This educational module covers completed CVOTs involving GLP-1 receptor agonists, treatment options for type 2 diabetes, study designs, results, and a timeline of new treatment o

0 views • 47 slides

Individuals with type 2 diabetes have an increased risk of cardiovascular events compared to those without the condition. Research indicates that certain GLP-1 receptor agonists have shown promising results in reducing cardiovascular events in diabetic patients with specific HbA1c levels. However, t

0 views • 69 slides

Narcotic analgesics, such as opiates and opioids derived from opium, interact with specific opioid receptors in the body to produce analgesic effects. Different opioid receptors have varying effects, with mu (MOP) being a good analgesic but with adverse effects, delta (DOP) and kappa (KOP) have nuan

0 views • 6 slides

Sympathomimetic amines like epinephrine, norepinephrine, isoproterenol, and dopamine are catecholamines with high potency but poor CNS penetration. Noncatecholamines like phenylephrine and ephedrine have longer half-lives. Learn about direct-acting, indirect-acting, and mixed-action adrenergic agoni

0 views • 25 slides

Explore the setup and procedures of a Pharmacology lab focusing on agonists and antagonists potency testing. Learn about equipment, tissue suspension, lab safety, lab plan, and health precautions. Follow instructions for conducting experiments, recording data, and cleaning up. Utilize resources prov

0 views • 28 slides